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unfavourable long-term functionaloutcome is very likely for stroke.12
Inflammation induced by pathogens or of autoimmune origin is par-
ticularly harmful to terminally differentiated organs with poor regen-
erative capacity, such as the heart and brain. Chronic inflammation is
thought to impair heart failure, neurodegenerative diseases, and
metabolic syndrome.13
Interestingly, increased resting heart rate has been linked to cogni-
tivedecline after ischaemic stroke.14 Thisobservation is supportedby
animal experiments demonstrating deleterious effects of chronic
stress on ischaemic brain injury mediated by increased heart rate.6
Interestingly, damage to the cerebral insular lobe (or ‘insula’) follow-
ing stroke or subarachnoid haemorrhage causes autonomic dysfunc-
tion and sympathetic overactivation (stress), and may lead to
neurocardiogenic damage and troponin elevation.4,15 Therefore,
not only may subclinical myocardial injury (as reflected by elevated
cTnT) lead to cognitive dysfunction, vice versa it is also possible
that brain injury (associated with cognitive dysfunction) causes
cardiac damage.15
Finally, we think that an important contribution has been made to
the heart and brain interaction. The roles of shared common harmful
mechanisms (e.g. autonomic nervous imbalance, inflammation), sub-
clinical (silent) stroke, and white matter disease need to be investi-
gated to uncover the heart of the matter.
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A 57-year-old gentleman was admitted with un-
stable angina with dynamic ECG changes (E), 4
days after discontinuation of dual antiplatelet
therapy (DAT) with aspirin and clopidogrel. He
had undergone staged percutaneous coronary
intervention with bioresorbable vascular scaffold
(BVS; ABSORB 1.1, Abbott Vascular, Santa Clara,
CA, USA) implantation in the ostial left circumflex
artery (LCx) 2 years ago (Panels A–D), followed
by everolimus-eluting metal stent implantation in
the distal left main and proximal left anterior des-
cending artery, with balloon dilation of the LCx
ostium. Fractional flow reserve of the LCx post-
intervention was 0.88.
At presentation, angiography showed a filling defect in the scaffolded segment (Panel F). Optical coherence tomography revealed intracor-
onary thrombus andscaffoldpattern irregularities (PanelsGandH ).Thepatientwastreatedwith thrombectomyandeverolimus-elutingmetal
stent implantation and discharged on aspirin and prasugrel.
To our knowledge, this is the first reported case of very late BVS thrombosis. Bioresorbable scaffolds have been suggested as an
alternative to metal platform drug-eluting stents, aiming to reduce very late stent complications, by providing transient support and
being completely integrated into the vascular wall after this period. Although, at 24 months significant bioresorption is expected to
have occurred with restoration of local vasomotion, there is still evidence of scaffold struts. In our case, scaffold thrombosis was observed
together with scaffold pattern irregularities. The possibility that the observed irregularities were induced by the balloon dilation performed
during left main metal stent implantation, subsequently leading to thrombosis, cannot be excluded. Importantly, the event occurred 4 days
after DAT discontinuation, suggesting a need for individualized duration of DAT in complex cases treated with BVS.
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